ATE266395T1 - Glycin zur vorbeugung oder behandlung von transplantatabstossungen - Google Patents

Glycin zur vorbeugung oder behandlung von transplantatabstossungen

Info

Publication number: ATE266395T1
Authority: AT; Austria
Prior art keywords: glycine; preventing; transplant rejection; treating transplant; treating
Prior art date: 1997-06-05

Application number

AT98110072T

Other languages

English (en)

Inventor

Heinz Schneider

Nigel Scott Cook

Original Assignee

Novartis Nutrition Ag

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1997-06-05

Filing date

1998-06-03

Publication date

2004-05-15

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=25353479&utm_source=***_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE266395(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

1998-06-03 Application filed by Novartis Nutrition Ag filed Critical Novartis Nutrition Ag

2004-05-15 Application granted granted Critical

2004-05-15 Publication of ATE266395T1 publication Critical patent/ATE266395T1/de

Links

DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 title abstract 4
239000004471 Glycine Substances 0.000 title abstract 2
206010052779 Transplant rejections Diseases 0.000 title abstract 2
230000001154 acute effect Effects 0.000 abstract 1
230000001684 chronic effect Effects 0.000 abstract 1
239000002955 immunomodulating agent Substances 0.000 abstract 1
229960003444 immunosuppressant agent Drugs 0.000 abstract 1
230000001861 immunosuppressant effect Effects 0.000 abstract 1
239000003018 immunosuppressive agent Substances 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
- A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
- A61K31/198—Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Immunology (AREA)
Veterinary Medicine (AREA)
Chemical & Material Sciences (AREA)
Public Health (AREA)
Medicinal Chemistry (AREA)
General Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
Pharmacology & Pharmacy (AREA)
Chemical Kinetics & Catalysis (AREA)
Organic Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Transplantation (AREA)
Epidemiology (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Solid-Sorbent Or Filter-Aiding Compositions (AREA)
Treatment Of Liquids With Adsorbents In General (AREA)
Coloring Foods And Improving Nutritive Qualities (AREA)

AT98110072T 1997-06-05 1998-06-03 Glycin zur vorbeugung oder behandlung von transplantatabstossungen ATE266395T1 (de)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
US86939897A	1997-06-05	1997-06-05

Publications (1)

Publication Number	Publication Date
ATE266395T1 true ATE266395T1 (de)	2004-05-15

Family

ID=25353479

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AT98110072T ATE266395T1 (de)	1997-06-05	1998-06-03	Glycin zur vorbeugung oder behandlung von transplantatabstossungen

Country Status (8)

Country	Link
EP (1)	EP0882451B1 (de)
JP (1)	JPH1112170A (de)
AT (1)	ATE266395T1 (de)
AU (1)	AU711090B2 (de)
CA (1)	CA2239582C (de)
DE (1)	DE69823739T2 (de)
ES (1)	ES2221095T3 (de)
ZA (1)	ZA984825B (de)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
AU4501799A (en) *	1998-05-29	1999-12-20	Novartis Nutrition Ag	A new use for glycine
CA2586239C (en) *	2004-11-02	2012-10-09	Oragenics, Inc.	Methods for regulating weight and size of animals with glycine
JOP20190146A1 (ar)	2016-12-19	2019-06-18	Axcella Health Inc	تركيبات حمض أميني وطرق لمعالجة أمراض الكبد
JP7266581B2 (ja)	2017-08-14	2023-04-28	アクセラ・ヘルス・インコーポレイテッド	肝疾患の治療のためのアミノ酸組成物
US10596136B2 (en)	2018-06-20	2020-03-24	Axcella Health Inc.	Compositions and methods for the treatment of fat infiltration in muscle
CN109758446A (zh) *	2019-03-22	2019-05-17	内蒙古自治区农牧业科学院	甘氨酸在作为奶山羊乳腺炎性应答的免疫调节剂中的应用

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5719133A (en) *	1994-09-21	1998-02-17	Novartis Nutrition Ag	Adolescent dietary composition
AU710527B2 (en) *	1995-02-23	1999-09-23	Novartis Nutrition Ag	Amino acid compositions and use thereof in clinical nutrition
CA2260886A1 (en) *	1996-07-30	1998-02-05	Novartis Nutrition Ag	Amino acid composition and use thereof in treating tumor growth and metastasis
US6096785A (en) *	1996-07-30	2000-08-01	Novartis Nutrition Ag	Amino acid compositions and use thereof in treating renal dysfunction

1998
- 1998-06-03 AT AT98110072T patent/ATE266395T1/de not_active IP Right Cessation
- 1998-06-03 CA CA002239582A patent/CA2239582C/en not_active Expired - Fee Related
- 1998-06-03 EP EP98110072A patent/EP0882451B1/de not_active Expired - Lifetime
- 1998-06-03 ES ES98110072T patent/ES2221095T3/es not_active Expired - Lifetime
- 1998-06-03 DE DE69823739T patent/DE69823739T2/de not_active Expired - Fee Related
- 1998-06-04 AU AU69899/98A patent/AU711090B2/en not_active Ceased
- 1998-06-04 JP JP10155930A patent/JPH1112170A/ja active Pending
- 1998-06-04 ZA ZA984825A patent/ZA984825B/xx unknown

Also Published As

Publication number	Publication date
CA2239582C (en)	2008-04-22
EP0882451B1 (de)	2004-05-12
JPH1112170A (ja)	1999-01-19
AU711090B2 (en)	1999-10-07
CA2239582A1 (en)	1998-12-05
DE69823739D1 (de)	2004-06-17
EP0882451A1 (de)	1998-12-09
AU6989998A (en)	1998-12-10
DE69823739T2 (de)	2005-04-28
ZA984825B (en)	1998-12-07
ES2221095T3 (es)	2004-12-16

Similar Documents

Publication	Publication Date	Title
DE69703649T2 (de)	2001-08-02	Behandlung von deagglomerierten teilchen mit plasmaaktivierter spezies
DE69711034D1 (de)	2002-04-18	Wässrige fluorpolymerlösungen zur behandlung von harten oberflächen
DE3779149D1 (de)	1992-06-25	Galanthamin oder dessen analoge zur behandlung der alzheimerschen krankheit.
MX9805810A (es)	1998-11-30	Agentes anticoagulantes, utiles en el tratamiento de trombosis.
MY113490A (en)	2002-03-30	Modified anti-icam-1 antibodies and their use in the treatment of inflammation
DK0931023T3 (da)	2002-08-19	Fremgangsmåde til behandling af ammoniakholdigt spildevand
ATE176759T1 (de)	1999-03-15	Methoden zur verminderung von sulfiden in abwassergas
EA199800011A1 (ru)	1998-06-25	Способ лечения или предупреждения остеопороза
ATE257189T1 (de)	2004-01-15	Verfahren zur behandlung von cellulosischen formkörpern
DE69415526D1 (de)	1999-02-04	Methode zur behandlung von wasserbehandlungsschlamm
DE69527140T2 (de)	2003-02-20	Wirkstoff zur prävention oder behandlung von osteoporose
ATE266395T1 (de)	2004-05-15	Glycin zur vorbeugung oder behandlung von transplantatabstossungen
DE69813022D1 (de)	2003-05-08	Injektor zur behandlung von metallschmelzen mit gasen
DE69104792D1 (de)	1994-12-01	Linsenbehandlungsvorrichtung für Kontaktlinsen und Verfahren zur Behandlung von Kontaktlinsen.
EA199800764A1 (ru)	1999-06-24	Способ лечения или предупреждения макулярного отека или возрастной макулярной дистрофии
ATE53302T1 (de)	1990-06-15	Mittel zur behandlung von wunden.
ZA978129B (en)	1998-03-20	Method of treating leather with improved retanning agents.
ES2176309T3 (es)	2002-12-01	Tratamiento humedo de pieles de cuero.
DE68900474D1 (de)	1992-01-09	Verfahren zur behandlung von organischem abwasser mit polyvinylpyridin.
DE69626816D1 (de)	2003-04-24	Verwendung von selegilin zur behandlung von gehörverlust bei säugetieren
ATE251462T1 (de)	2003-10-15	Verfahren zur behandlung von narbengewebe
DE69111324T2 (de)	1996-01-04	Vorrichtung zur Behandlung oder Trennung von Gasen.
DE68907569D1 (de)	1993-08-19	Mittel zur behandlung oder vorbeugung von aids.
EP0888780A4 (de)	2001-02-28	Zusammensetzung zur behandlung von kontaktlinsen und methode zur anwendung derselben
ATE124727T1 (de)	1995-07-15	Verfahren zur behandlung von häuten und so erhaltene häute.

Legal Events

Date	Code	Title	Description
2005-01-15	UEP	Publication of translation of european patent specification	Ref document number: 0882451 Country of ref document: EP
2005-05-15	EEIH	Change in the person of patent owner
2009-07-15	EEIH	Change in the person of patent owner
2010-03-15	REN	Ceased due to non-payment of the annual fee